Showing results (111-120 of 176) with videos related to

Sort By:
Pageof 18
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 27, 2025
Immune Composition and Immunotherapy Outcomes of Mesothelioma With BAP1, CDKN2A, MTAP, and NF2 AlterationsIbiayi Dagogo-Jack, Owen Mitchell, Elizabeth Codd, et al.
Transplantation|April 1, 2011
Approaches to avoid immune responses induced by repeated subcutaneous injections of allogeneic umbilical cord tissue-derived cellsBram V Lutton, Patricia S Cho, Erica L Hirsh, et al.
The Oncologist|August 21, 2013
β-Catenin mutation status and outcomes in sporadic desmoid tumorsJohn T Mullen, Thomas F DeLaney, Andrew E Rosenberg, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 5, 2008
Effects of erlotinib in EGFR mutated non-small cell lung cancers with resistance to gefitinibDaniel B Costa, Kim-Son H Nguyen, Byoung C Cho, et al.
The Lancet. Oncology|February 3, 2016
Long-term toxic effects of proton radiotherapy for paediatric medulloblastoma: a phase 2 single-arm studyTorunn I Yock, Beow Y Yeap, David H Ebb, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|October 12, 2014
Quality of life outcomes in proton and photon treated pediatric brain tumor survivorsTorunn I Yock, Sundeep Bhat, Jackie Szymonifka, et al.
NPJ Precision Oncology|October 31, 2018
Pretreatment plasma HGF as potential biomarker for susceptibility to radiation-induced liver dysfunction after radiotherapyTheodore S Hong, Clemens Grassberger, Beow Y Yeap, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 25, 2010
Donor-derived second hematologic malignancies after cord blood transplantationKaren K Ballen, Corey Cutler, Beow Y Yeap, et al.
Science Translational Medicine|October 15, 2011
Diabetes impairs hematopoietic stem cell mobilization by altering niche functionFrancesca Ferraro, Stefania Lymperi, Simón Méndez-Ferrer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 5, 2006
Exon 19 deletion mutations of epidermal growth factor receptor are associated with prolonged survival in non-small cell lung cancer patients treated with gefitinib or erlotinibDavid M Jackman, Beow Y Yeap, Lecia V Sequist, et al.
Pageof 18